8-K
Merck Announces Third-Quarter 2026 Financial Results and Raises Full-Year Sales and EPS Outlook
8-K
Paul J. Diaz Elected to Merck & Co., Inc. Board of Directors
8-K
Merck Announces Second-Quarter 2026 Financial Results and Raises Full-Year Outlook
8-K
Merck & Co., Inc. Announces Results of 2026 Annual Meeting of Shareholders
8-K
Merck & Co., Inc. Completes $6 Billion Public Offering of Senior Notes
8-K
Merck Announces First-Quarter 2026 Financial Results and Strategic Pipeline Expansion
